Glenn W. Welling - Engaged Capital 13F Activity & Position Changes (Q4 2023)

As of Dec 31, 2023, the Engaged Capital portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Feb 14, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2023, the filing reported:

New Buys - NCR Atleos Corporation, Nevro Corp., PRA Group, Inc.

Increases - BRC Inc., Evolent Health, Inc, V.F. Corporation

Reductions - Upbound Group, Inc.

Complete Exits - Primo Water Corporation

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q4 2023	BRCC BRC Inc.	BRC Inc.	Buy	+400,000	+3.2%	$46.65M	12,851,018
Q4 2023	EVH Evolent Health, Inc	Evolent Health, Inc	Buy	+428,648	+15.1%	$107.73M	3,261,458
Q4 2023	NATL NCR Atleos Corporation	NCR Atleos Corporation	Buy - Position Entry	+2,509,256	-	$60.95M	2,509,256
Q4 2023	NVRO Nevro Corp.	Nevro Corp.	Buy - Position Entry	+2,168,163	-	$46.66M	2,168,163
Q4 2023	PRAA PRA Group, Inc.	PRA Group, Inc.	Buy - Position Entry	+2,010,750	-	$52.68M	2,010,750
Q4 2023	PRMW Primo Water Corporation	Primo Water Corporation	Sell - Position Exit	-878,751	-100.0%	$0.00	-
Q4 2023	UPBD Upbound Group, Inc.	Upbound Group, Inc.	Sell	-1,270,457	-34.6%	$81.42M	2,396,916
Q4 2023	VFC V.F. Corporation	V.F. Corporation	Buy	+145,084	+2.8%	$100.42M	5,341,368